| URL | https://www.reuters.com/business/healthcare-pharma |
| Source | Reuters |
| Date Published | 03/03/2025 |
| Author Name | Christy Santhosh |
| Company/Division name | Pending Tariffs- Pfizer |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2025 |
| Domestically, the work will be done: | In-house |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharmaceuticals |
| What non-domestic negative factors made offshoring less attractive? | Tariffs |